Please assess the completion status of the following clinical trial:

Trial Title: A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects must have failed or are intolerant to anti TNFs~* hsCRP greater or equal to 5.0 mg/L~* Ulcerations demonstrated by colonoscopy as defined by SES CD assessment performed within 8 weeks of study entry (screening) and able to retrospectively complete the SES-CD or colonoscopy performed during screening~Exclusion Criteria:~* Pregnant or breastfeeding women~* Crohn's Disease with active fistulae or abscess~* History of diverticulitis or symptomatic diverticulosis~* Abnormality in hematology or chemistry profiles at screening

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Placebo- SC injection (Type: PLACEBO_COMPARATOR): None
- Drug Dose level 1 - SC injection (Type: EXPERIMENTAL): None
- Drug Dose level 2 - SC injection (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).